Why is Titan Biotech falling/rising?

As of 08-Jul, Titan Biotech Ltd's stock is currently priced at 458.00, reflecting an increase of 2.0 (0.44%). The stock has outperformed its sector today by 1.02%, although it is trading below its 100-day and 200-day moving averages, indicating some short-term weakness. Over the past week, Titan Biotech has shown a strong return of +12.54%, while its performance over the past month is +7.76%. However, the company has faced challenges, including negative results for the last three consecutive quarters, which have contributed to a poor long-term growth outlook. Despite a high return on equity (ROE) of 25.08% and a low debt-to-equity ratio, the stock's valuation remains high compared to its peers, which may deter some investors.
In the broader market context, while the Sensex has shown a minimal increase of +0.02% over the past week, Titan Biotech's significant short-term gains indicate a divergence from the overall market trend. The stock has underperformed the market over the past year, with a return of -22.37% compared to the BSE500's +1.98%. This underperformance, coupled with declining investor participation and a decrease in delivery volume, suggests that while there may be short-term optimism reflected in today's price movement, the long-term outlook remains uncertain due to the company's recent financial struggles.